Breaking News

FBI Says North Korean Government Responsible for Sony Hack
Tweet TWEET

SWISS DAYBOOK: Synthes, Nestle, Sonova, Santhera

Synthes Inc. (SYST), the medical-device maker that’s agreed to be acquired by Johnson & Johnson, posted an 11 percent increase in third-quarter sales on growth in Europe and Asia. Third-quarter revenue climbed to $1 billion from $907.2 million a year earlier, the company said. Sales topped $1 billion for the first time.

EQUITIES: *Sonova Holding AG (SOON)’s first-half sales were 763 million Swiss francs ($852 million). *Santhera Pharmaceuticals says it will present data on Catena for the treatment of Duchenne muscular dystrophy. *Nestle plans to increase its number of brands, CEO Paul Bulcke said in interview

ECONOMICS/POLITICS: *Swiss government holds regular meeting at 9:00 a.m.

MARKETS: *The benchmark SMI declined 0.7 percent to 5,682.51 *The SPI fell 0.6 percent to 5,148.34 *The Stoxx Europe 600 Index lost 0.4 percent to 235.33 *The MSCI Asia-Pacific Index gained 0.8 percent at 7:30 a.m. Swiss time *Euro-franc traded at 1.2376 at 7:31 a.m.

To contact the reporter on this story: Klaus Wille in Zurich at kwille@bloomberg.net

To contact the editor responsible for this story: Craig Stirling at cstirling1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.